Premier Biomedical (Premier Biomedical) Common Stock : $0.00 Mil (As of Dec. 2019)

View and export this data going back to 2012. Start your Free Trial

What is Premier Biomedical Common Stock?

Premier Biomedical's quarterly common stock increased from Jun. 2019 ($0.00 Mil) to Sep. 2019 ($0.00 Mil) and increased from Sep. 2019 ($0.00 Mil) to Dec. 2019 ($0.00 Mil).

Premier Biomedical's annual common stock stayed the same from Dec. 2017 ($0.00 Mil) to Dec. 2018 ($0.00 Mil) but then increased from Dec. 2018 ($0.00 Mil) to Dec. 2019 ($0.00 Mil).

Premier Biomedical Common Stock Historical Data

The historical data trend for Premier Biomedical's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Premier Biomedical Common Stock Chart

Premier Biomedical Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Common Stock

Get a 7-Day Free Trial

Premier Biomedical Quarterly Data
	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19
Common Stock	Get a 7-Day Free Trial															-	-	-	-	-

Premier Biomedical Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Premier Biomedical (Premier Biomedical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Premier Biomedical Inc (OTCPK:BIEI) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

2409 Sycamore Drive, Knoxville, TN, USA, 37921

Website

https://www.premiergrapheneinc.com

Premier Biomedical Inc is engaged in a hemp-based initiative, developing graphene-enhanced formulations for a myriad of commercial and military applications.